Johnson & Johnson's 340B model prompts AHA to call for fines

Having trouble viewing this email? See the online version

Friday, August 30, 2024 Friday, August 30, 2024 Hospitals seek fines against Johnson and Johnson in 340B battle The government said it is prepared to take action after the company announced it will require eligible hospitals to apply for rebates for certain medications. Read More > RELATED ARTICLES 340B is back on deck in Congress after Chevron, but hurdles loom Rural hospital CEOs plead for better reimbursement to avert cuts States build momentum to protect 340B drug discounts - for now Leaders like you are also reading Centene to cut broker commissions on Part D drug plans for 2025 Centene's decision to stop Medicare Part D broker commissions threatens brokers and plan members, said a trade grou... READ MORE > Pfizer launches website to sell directly to patients Pfizer launched a website Tuesday for scheduling vaccine appointments and virtual doctor visits, with prescriptions... READ MORE > Prior authorization targeted by more and more states Frustration among providers and patients with health insurance red tape is spurring state policymakers to curb prio... READ MORE > How 3 health systems decide when to buy or build AI Executives from Providence, Ochsner Health and Hartford HealthCare weigh their options on artificial intelligence, ... READ MORE > UNLOCK YOUR ACCESS Discover the latest news, insight & analysis needed to navigate the healthcare industry. VIEW OUR SUBSCRIPTION OFFERS This email was sent to chunduri22.covid@blogger.com Manage My Account | Contact Us   © 2024 Modern Healthcare 130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States Privacy Policy | Terms and Conditions | Unsubscribe